Phytomedicine as a source of SGLT2 inhibitors, GLP-1 secretagogues and DPP-IV inhibitors for mitigation of Diabetic Nephropathy

類似資料

• The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system
  著者:: Schernthaner, Guntram, 等
  出版事項: (2014)
• SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review
  著者:: El Mouhayyar, Christopher, 等
  出版事項: (2020)
• Lower-limb amputations in patients treated with SGLT2 inhibitors versus DPP-4 inhibitors: A meta-analysis of observational studies
  著者:: Andre J. Scheen
  出版事項: (2022-04-01)
• The placebo response of injectable GLP‐1 receptor agonists vs. oral DPP‐4 inhibitors and SGLT‐2 inhibitors: a systematic review and meta‐analysis
  著者:: de Wit, Helena M., 等
  出版事項: (2016)
• Clinical Use of DPP-4 Inhibitors
  著者:: Baptist Gallwitz
  出版事項: (2019-06-01)